Industry Report #10｜First ANGPTL3 Small Nucleic Acid Drug Submits Clinical Trial Application in China
Angiopoietin-like protein 3 (ANGPTL3) is a protein involved in fat metabolism and blood vessel formation. Variations in the ANGPTL3 gene can lead to familial hypercholesterolemia (HoFH). On January 31, the clinical trial application for JS401 injection, jointly developed by Runjia Pharmaceuticals and Shanghai Junshi Bioscience and Technology Co., Ltd., received approval from the National Medical…
In Transcription. @UCLA 